Page 1 | Search Results | Journal of Experimental Medicine

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Addendum: Resolvins suppress tumor growth and enhance cancer therapy

J Exp Med (2024) 221 (3): e2017068101232024a.

https://doi.org/10.1084/jem.2017068101232024a

Published: 31 January 2024

View article titled, Addendum: Resolvins suppress tumor growth and enhance cancer therapy

Journal Articles

Resolvins suppress tumor growth and enhance cancer therapy

In Special Collection:

2018: The Year in Experimental Medicine , Cancer 2018 , Cancer Plasticity and Heterogeneity , Cell Death, Inflammation, and Adaptation to Tissue Stress , Translational Immunology 2018

J Exp Med (2017) 215 (1): 115–140.

https://doi.org/10.1084/jem.20170681

Published: 30 November 2017

View article titled, Resolvins suppress tumor growth and enhance cancer therapy

Includes: Supplementary data

Journal Articles

Identification of resolvin D2 receptor mediating resolution of infections and organ protection

Nan Chiang, Jesmond Dalli, Romain A. Colas, Charles N. Serhan

J Exp Med (2015) 212 (8): 1203–1217.

https://doi.org/10.1084/jem.20150225

Published: 20 July 2015

View article titled, Identification of resolvin D2 receptor mediating resolution of infections and organ protection

Journal Articles

Vagus nerve controls resolution and pro-resolving mediators of inflammation

Valbona Mirakaj, Jesmond Dalli, Tiago Granja, Peter Rosenberger, Charles N. Serhan

J Exp Med (2014) 211 (6): 1037–1048.

https://doi.org/10.1084/jem.20132103

Published: 26 May 2014

View article titled, Vagus nerve controls resolution and pro-resolving mediators of inflammation

Includes: Supplementary data

Journal Articles

Native and aspirin-triggered lipoxins control innate immunity by inducing proteasomal degradation of TRAF6

Fabiana S. Machado, Lísia Esper, Alexandra Dias, Rajat Madan, YuanYuan Gu, David Hildeman, Charles N. Serhan, Christopher L. Karp, Júlio Aliberti

J Exp Med (2009) 206 (11): 2573.

https://doi.org/10.1084/jem.2007241692209r

Published: 05 October 2009

View article titled, Native and aspirin-triggered lipoxins control innate immunity by inducing proteasomal degradation of TRAF6

Journal Articles

Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions

Charles N. Serhan, Rong Yang, Kimberly Martinod, Kie Kasuga, Padmini S. Pillai, Timothy F. Porter, Sungwhan F. Oh, Matthew Spite

J Exp Med (2008) 206 (1): 15–23.

https://doi.org/10.1084/jem.20081880

Published: 22 December 2008

View article titled, Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions

Includes: Supplementary data

Journal Articles

Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE₂ and LXA₄ in the induction of macrophage death

Minjian Chen, Maziar Divangahi, Huixian Gan, Daniel S.J. Shin, Song Hong, David M. Lee, Charles N. Serhan, Samuel M. Behar, Heinz G. Remold

J Exp Med (2008) 205 (12): 2791–2801.

https://doi.org/10.1084/jem.20080767

Published: 27 October 2008

View article titled, Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death

Includes: Supplementary data

Journal Articles

Native and aspirin-triggered lipoxins control innate immunity by inducing proteasomal degradation of TRAF6

Fabiana S. Machado, Lísia Esper, Alexandra Dias, Rajat Madan, YuanYuan Gu, David Hildeman, Charles N. Serhan, Christopher L. Karp, Júlio Aliberti

J Exp Med (2008) 205 (5): 1077–1086.

https://doi.org/10.1084/jem.20072416

Published: 14 April 2008

View article titled, Native and aspirin-triggered lipoxins control innate immunity by inducing proteasomal degradation of TRAF6

Includes: Supplementary data

Journal Articles

Thromboxane A₂ is a key regulator of pathogenesis during Trypanosoma cruzi infection

Anthony W. Ashton, Shankar Mukherjee, FNU Nagajyothi, Huan Huang, Vicki L. Braunstein, Mahalia S. Desruisseaux, Stephen M. Factor, Lillie Lopez, Joan W. Berman, Murray Wittner, Philipp E. Scherer, Valerie Capra, Thomas M. Coffman, Charles N. Serhan, Katherine Gotlinger, Kenneth K. Wu, Louis M. Weiss, Herbert B. Tanowitz

J Exp Med (2007) 204 (4): 929–940.

https://doi.org/10.1084/jem.20062432

Published: 09 April 2007

View article titled, Thromboxane A2 is a key regulator of pathogenesis during Trypanosoma cruzi infection

Journal Articles

Lipoxins and aspirin-triggered lipoxin inhibit inflammatory pain processing

Camilla I. Svensson, Michela Zattoni, Charles N. Serhan

J Exp Med (2007) 204 (2): 245–252.

https://doi.org/10.1084/jem.20061826

Published: 22 January 2007

View article titled, Lipoxins and aspirin-triggered lipoxin inhibit inflammatory pain processing

Includes: Supplementary data

Journal Articles

Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1

Makoto Arita, Francesca Bianchini, Julio Aliberti, Alan Sher, Nan Chiang, Song Hong, Rong Yang, Nicos A. Petasis, Charles N. Serhan

J Exp Med (2005) 201 (5): 713–722.

https://doi.org/10.1084/jem.20042031

Published: 07 March 2005

View article titled, Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1

Includes: Supplementary data

Journal Articles

Resolvins : A Family of Bioactive Products of Omega-3 Fatty Acid Transformation Circuits Initiated by Aspirin Treatment that Counter Proinflammation Signals

Charles N. Serhan, Song Hong, Karsten Gronert, Sean P. Colgan, Pallavi R. Devchand, Gudrun Mirick, Rose-Laure Moussignac

J Exp Med (2002) 196 (8): 1025–1037.

https://doi.org/10.1084/jem.20020760

Published: 21 October 2002

View article titled, Resolvins : <subtitle>A Family of Bioactive Products of Omega-3 Fatty Acid Transformation Circuits Initiated by Aspirin Treatment that Counter Proinflammation Signals </subtitle>

Journal Articles

Novel Functional Sets of Lipid-Derived Mediators with Antiinflammatory Actions Generated from Omega-3 Fatty Acids via Cyclooxygenase 2–Nonsteroidal Antiinflammatory Drugs and Transcellular Processing

Charles N. Serhan, Clary B. Clish, Jessica Brannon, Sean P. Colgan, Nan Chiang, Karsten Gronert

J Exp Med (2000) 192 (8): 1197–1204.

https://doi.org/10.1084/jem.192.8.1197

Published: 16 October 2000

View article titled, Novel Functional Sets of Lipid-Derived Mediators with Antiinflammatory Actions Generated from Omega-3 Fatty Acids via Cyclooxygenase 2–Nonsteroidal Antiinflammatory Drugs and Transcellular Processing

Journal Articles

The Scent of a Phagocyte: Advances on Leukotriene B₄ Receptors

Charles N. Serhan, Stephen M. Prescott

J Exp Med (2000) 192 (3): F5–F8.

https://doi.org/10.1084/jem.192.3.F5

Published: 08 August 2000

View article titled, The Scent of a Phagocyte: <subtitle>Advances on Leukotriene B4 Receptors</subtitle>

Journal Articles

Activation of Lipoxin a₄ Receptors by Aspirin-Triggered Lipoxins and Select Peptides Evokes Ligand-Specific Responses in Inflammation

Nan Chiang, Iolanda M. Fierro, Karsten Gronert, Charles N. Serhan

J Exp Med (2000) 191 (7): 1197–1208.

https://doi.org/10.1084/jem.191.7.1197

Published: 03 April 2000

View article titled, Activation of Lipoxin a4 Receptors by Aspirin-Triggered Lipoxins and Select Peptides Evokes Ligand-Specific Responses in Inflammation

Journal Articles

Lipoxin (LX)A₄ and Aspirin-triggered 15-epi-LXA₄ Inhibit Tumor Necrosis Factor 1α–initiated Neutrophil Responses and Trafficking: Regulators of a Cytokine–Chemokine Axis

Mohamed Hachicha, Marc Pouliot, Nicos A. Petasis, Charles N. Serhan

J Exp Med (1999) 189 (12): 1923–1930.

https://doi.org/10.1084/jem.189.12.1923

Published: 21 June 1999

View article titled, Lipoxin (LX)A4 and Aspirin-triggered 15-epi-LXA4 Inhibit Tumor Necrosis Factor 1α–initiated Neutrophil Responses and Trafficking: Regulators of a Cytokine–Chemokine Axis

Journal Articles

Identification of a Human Enterocyte Lipoxin A₄ Receptor That Is Regulated by Interleukin (IL)-13 and Interferon γ and Inhibits Tumor Necrosis Factor α–induced IL-8 Release

Karsten Gronert, Andrew Gewirtz, James L. Madara, Charles N. Serhan

J Exp Med (1998) 187 (8): 1285–1294.

https://doi.org/10.1084/jem.187.8.1285

Published: 20 April 1998

View article titled, Identification of a Human Enterocyte Lipoxin A4 Receptor That Is Regulated by Interleukin (IL)-13 and Interferon γ and Inhibits Tumor Necrosis Factor α–induced IL-8 Release

Journal Articles

Aspirin-triggered 15-Epi-Lipoxin A₄ (LXA₄) and LXA₄ Stable Analogues Are Potent Inhibitors of Acute Inflammation: Evidence for Anti-inflammatory Receptors

Tomoko Takano, Stefano Fiore, Jane F. Maddox, Hugh R. Brady, Nicos A. Petasis, Charles N. Serhan

J Exp Med (1997) 185 (9): 1693–1704.

https://doi.org/10.1084/jem.185.9.1693

Published: 05 May 1997

View article titled, Aspirin-triggered 15-Epi-Lipoxin A4 (LXA4) and LXA4 Stable Analogues Are Potent Inhibitors of Acute Inflammation: Evidence for Anti-inflammatory Receptors

NARROW

Addendum: Resolvins suppress tumor growth and enhance cancer therapy

Resolvins suppress tumor growth and enhance cancer therapy

Identification of resolvin D2 receptor mediating resolution of infections and organ protection

Vagus nerve controls resolution and pro-resolving mediators of inflammation

Native and aspirin-triggered lipoxins control innate immunity by inducing proteasomal degradation of TRAF6

Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions

Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE₂ and LXA₄ in the induction of macrophage death

Native and aspirin-triggered lipoxins control innate immunity by inducing proteasomal degradation of TRAF6

Thromboxane A₂ is a key regulator of pathogenesis during Trypanosoma cruzi infection

Lipoxins and aspirin-triggered lipoxin inhibit inflammatory pain processing

Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1

Resolvins : A Family of Bioactive Products of Omega-3 Fatty Acid Transformation Circuits Initiated by Aspirin Treatment that Counter Proinflammation Signals

Novel Functional Sets of Lipid-Derived Mediators with Antiinflammatory Actions Generated from Omega-3 Fatty Acids via Cyclooxygenase 2–Nonsteroidal Antiinflammatory Drugs and Transcellular Processing

The Scent of a Phagocyte: Advances on Leukotriene B₄ Receptors

Activation of Lipoxin a₄ Receptors by Aspirin-Triggered Lipoxins and Select Peptides Evokes Ligand-Specific Responses in Inflammation

Lipoxin (LX)A₄ and Aspirin-triggered 15-epi-LXA₄ Inhibit Tumor Necrosis Factor 1α–initiated Neutrophil Responses and Trafficking: Regulators of a Cytokine–Chemokine Axis

Identification of a Human Enterocyte Lipoxin A₄ Receptor That Is Regulated by Interleukin (IL)-13 and Interferon γ and Inhibits Tumor Necrosis Factor α–induced IL-8 Release

Aspirin-triggered 15-Epi-Lipoxin A₄ (LXA₄) and LXA₄ Stable Analogues Are Potent Inhibitors of Acute Inflammation: Evidence for Anti-inflammatory Receptors

Email alerts

Email alerts

This Feature Is Available To Subscribers Only